HomeCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Nakaraang pagsara
$7.50
Sakop ng araw
$7.20 - $8.58
Sakop ng taon
$5.20 - $22.20
Market cap
2.44M USD
Average na Volume
4.55K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.00K | -37.50% |
Gastos sa pagpapatakbo | 2.19M | -68.12% |
Net na kita | -1.96M | 67.56% |
Net profit margin | -19.57K | 48.09% |
Kita sa bawat share | -0.18 | 97.55% |
EBITDA | -2.18M | 68.18% |
Aktuwal na % ng binabayarang buwis | 9.69% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.98M | -49.83% |
Kabuuang asset | 5.38M | -56.94% |
Kabuuang sagutin | 6.35M | -22.55% |
Kabuuang equity | -970.00K | — |
Natitirang share | 6.29M | — |
Presyo para makapag-book | -16.67 | — |
Return on assets | -80.21% | — |
Return on capital | -32,014.71% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.96M | 67.56% |
Cash mula sa mga operasyon | -3.07M | 24.01% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | -1.00K | 98.00% |
Net change in cash | -3.02M | 28.48% |
Malayang cash flow | -2.31M | 8.20% |
Tungkol
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Itinatag
Ago 13, 1996
Headquarters
Website
Mga Empleyado
12
